Robust and Cost-Effective Pharmacological Immunosuppression Enables Establishment of Nigerian Patient-Derived Xenograft (PDX) Models of Triple-Negative Breast Cancer (TNBC) in Low-Resource Settings

Uzoamaka Adaobi Okoli(University College London), Iroka J. Udeinya(University of Nigeria)
Research Square
June 24, 2025
Cited by 0


Related Papers

No related papers found

Powered by citation graph analysis